Strong Quarter at Regeneron – Analyst Blog

By Scalper1 | October 29, 2012

Regeneron Pharmaceuticals Inc. ‘s ( REGN ) third quarter 2012 earnings (excluding special items but including stock-based compensation) of $1.70 per share breezed past the Zacks